| Mrs Melinda Ann Jackson, | |
|
13007 Ne Glisan St, Portland, OR 97230-2545 | |
| (503) 215-6556 | |
| (503) 215-0685 |
| Full Name | Mrs Melinda Ann Jackson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 13007 Ne Glisan St, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558330647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | MD12772 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melinda Ann Jackson, 13007 Ne Glisan St, Portland, OR 97230-2545 Ph: (503) 215-6556 | Mrs Melinda Ann Jackson, 13007 Ne Glisan St, Portland, OR 97230-2545 Ph: (503) 215-6556 |
News Archive
For their ability to differentiate into other cell types, the embryonic stem cells hold a large potential in the medical industry. Their use, however, poses ethical questions due to the fact that in order to obtain them, it is necessary to destroy the embryo. For this reason, medical researches use the so-called induced pluripotent stem cells (iPSC). In fact, it is possible to reprogram adult cells that can be obtained by simply drawing blood and making them "regress" to a similar state to that of embryonic stem cells.
The ability to 3D print a variety of healthcare-related products in deployment zones would greatly benefit the nation's warfighters.
Tolerx, Inc., a biopharmaceutical company developing novel therapies by modulating T cell activity, and the Cancer Vaccine Acceleration Fund (CVAF) a nonprofit program of the Cancer Research Institute established in partnership with the Ludwig Institute for Cancer Research today announced they entered into a collaborative research agreement to support development of Tolerx's drug candidate, TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Cancer cases may have manifested as brain tumors in the local population in Upper Hunter Valley as a result of pollution from mines and power stations. With five residents in a single block in Singleton being diagnosed with brain tumors a public inquiry to establish just how harmful dust and toxins from the mines and power stations are had been constituted by the state government.
› Verified 9 days ago
Salona Shrestha, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |